Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 218 shares at $779.00 ($170K) on 2022-12-08, disclosed to the SEC on 2022-12-12.
Open-market sale of $170k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-08-19 | $885K | — | Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |